Skip to main content

Patent Prosecution in Jordan.

Patent prosecution in Jordan involves a series of steps to obtain patent protection for an invention within the country. 

Here's an overview:

1. Patent Search: 

Begin by conducting a patent search to ensure your invention is novel and not already patented in Jordan. This can be done through the Jordanian Patent Office (JPO) or online databases.

2.Draft a Patent Application: 

Prepare a detailed patent application describing your invention's technical aspects, including drawings and claims. It's advisable to seek legal counsel or a patent attorney experienced in Jordanian patent law for assistance.

3.Filing the Application: 

Submit your patent application to the JPO. Ensure it complies with the required format and includes all necessary documentation. Pay the filing fees.

4. Examination: 

The JPO will examine your application to determine its patentability. This process may involve correspondence and amendments to the application if required.

5. Publication: 

Once the JPO approves your patent application, it will be published in the Official Gazette, allowing for public review and potential opposition.

6.Grant of Patent: 

If there are no objections or oppositions, and your application meets all requirements, the JPO will grant you a patent.

7.Maintenance and Annuities: 

To keep your patent in force, you must pay annual maintenance fees to the JPO.

8.Enforcement: 

If someone infringes on your patent rights in Jordan, you can take legal action through the Jordanian courts to enforce your rights and seek remedies.

9.International Considerations: 

If you plan to seek patent protection in multiple countries, consider filing under the Patent Cooperation Treaty (PCT) or other international agreements to simplify the process.

Note: 

Patent law is complex, and it's advisable to consult with a qualified patent attorney or agent familiar with Jordanian patent law to navigate the process effectively. Additionally, patent laws and procedures may change over time, so it's essential to check with the Jordanian Patent Office for the most up-to-date information.

Comments

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcur...

Corona virus (Covid-19)

The only way one can combat with Covid-19 is by building one’s immunity & staying healthy by proper hygiene Best medicines for immunity development could be multivitamin pills with zinc,and best foods could be #freshfruits #vegetables. #Mangoes #lemon #oranges are could be the best.

Biogen to seek approval for high-dose version of Spinal Muscular Atrophy stalwart Spinraza (Nusinersen) after trial win

Biogen, which was first to score an endorsement in Spinal Muscular Atrophy (SMA) in 2016, is endeavoring to address it with a higher portion variant of Spinraza #(Nusinersen). On Wednesday, the organization uncovered that a part of its stage 2/3 Commit concentrate on met its essential endpoint, as a higher portion of Spinraza worked on the engine capability of treatment-innocent newborn children with SMA. The review contrasted the high-portion routine with a coordinated, untreated hoax control bunch from the stage 3 Charm study, which empowered Spinraza's unique endorsement. In the Commit preliminary accomplice, 75 patients were randomized 2:1 to get the higher-portion routine or the FDA-endorsed dose of 12 mg, which incorporates four beginning medicines, trailed by support dosages like clockwork. While the high-portion form of Spinraza met the preliminary's endpoint contrasted with joke, the outcomes too "moved in favor" of the investigational routine contrasted with...